Harneet Walia

Dr. Harneet Walia


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2014 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
PDF file
HWHarneet Walia
Harneet Walia
HLHong Li
Hong Li
MRMichael Rueschman
Michael Rueschman
DBDeepak L. Bhatt
Deepak L. Bhatt
SPSanjay Patel
Sanjay Patel
RMReena Mehra
Reena Mehra
We hypothesized that untreated severe obstructive sleep apnea (OSA) is associated with elevated ambulatory blood pressure (BP) in subjects with high cardiovascular disease (CVD) risk despite medical management. Data from the baseline examination of the Heart Biomarker Evaluation in Apnea Treatment (HeartBEAT) study, a 4-site randomized controlled trial were analyzed. Individuals with moderate-severe OSA (apnea hypopnea index, AHI = 15-50) and cardiovascular risk were recruited from cardiology practices. Those with hypertension were included. Intensive antihypertensive regimen (IAR) was defined as ≥ 3 antihypertensives including a diuretic. Definitions were: controlled BP (BP < 130/80), uncontrolled elevated BP (BP ≥ 130/80 not on IAR) and resistant elevated BP (BP ≥ 130/80 mm Hg despite IAR). Associations of untreated severe OSA (AHI ≥ 30) and uncontrolled and resistant elevated BP were evaluated using logistic regression analyses adjusted for age, sex, race, body mass index, smoking status, diabetes, and CVD. Among the 284 participants (mean age 63.1 ± 7.2 years, 23.6% with severe OSA), 61.6% had controlled BP, 28.5% had uncontrolled elevated BP, and 9.9% had resistant elevated BP. Among participants prescribed IAR, resistant elevated BP was more prevalent in those with severe compared to moderate OSA (58.3% vs. 28.6%, p = 0.01). Participants with severe OSA had a 4-fold higher adjusted odds of resistant elevated BP (OR 4.1, 95% CI: 1.7-10.2), a finding not reproduced in the absence of IAR use. Among patients with increased cardiovascular risk and moderate to severe OSA, untreated severe compared to moderate OSA was associated with elevated BP despite IAR suggesting untreated severe OSA contributes to poor BP control despite aggressive medication use. A commentary on this article appears in this issue on page 845.

1 November 2013 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Open access
PDF file
SDSaurabh Dahiya
Saurabh Dahiya
MAManmeet S. Ahluwalia
Manmeet S. Ahluwalia
HWHarneet Walia
Harneet Walia
Sleep-related complaints are extremely common in patients with cancer but often are not recognized, and even if they are, they are seldom treated. Recognizing insomnia in cancer patients is imperative, as appropriate treatment can improve quality of life.

1 January 2020 in Chest
Verified
Journal Article
Closed access
HWHarneet Walia
Harneet Walia
NTNicolas R. Thompson
Nicolas R. Thompson
KSKingman P. Strohl
Kingman P. Strohl
MFMichael D. Faulx
Michael D. Faulx
TWTina Waters
Tina Waters
RMReena Mehra
Reena Mehra

Verified
Journal Article
Open access
PDF file
HWHarneet Walia
Harneet Walia
RMReena Mehra
Reena Mehra
Sleep disorders are very common, often under-recognized and therefore undertreated, are associated with a myriad of medical conditions and could lead to significant impairment of quality of life. This review provides an up-to-date synopsis of common sleep disorders encompassing insufficient sleep syndrome, insomnia, circadian rhythm disorders and obstructive sleep apnea with a brief overview of epidemiology, screening, diagnostic testing and treatment. We also emphasize the emerging area of the intersection of sleep disorders and dermatologic conditions and present compelling data regarding underlying mechanisms including sleep dysfunction in relation to disorders of skin inflammation, aging and skin cancer.

1 March 2016 in Chest
Verified
Journal Article
Closed access
HWHarneet Walia
Harneet Walia
SGSandra D. Griffith
Sandra D. Griffith
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer
GTGeorge Thomas
George Thomas
EBEmmanuel L. Bravo
Emmanuel L. Bravo
RMReena Mehra
Reena Mehra

1 September 2019 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Closed access
HWHarneet Walia
Harneet Walia
Obstructive sleep apnea (OSA) is a serious condition associated with impaired quality of life, depression, drowsy driving and motor vehicle accidents, metabolic disease, and cognitive decline. The mechanisms accounting for OSA and metabolic disease include hypoxia, sleep fragmentation, and systemic inflammation. OSA appears to advance cognitive decline, and the relationship between the 2 conditions may be bidirectional. Treatment of patients with continuous positive air pressure therapy improves many of the impaired outcomes associated with OSA. Greater awareness, screening, and treatment of patients with OSA can reduce the negative consequences associated with OSA.